Pharmacokinetic-Pharmacodynamic (PKPD) Characterization of MAM01, an investigational Monoclonal Antibody with extended half-life Targeting Plasmodium falciparum Sporozoites, Using a Controlled Human Malaria Infection Model (CHMI)

MAM01 - Atreca, Bill & Melinda Gates Foundation

https://plan.core-apps.com/astmh25/abstract/bd4b6ac4-0233-4054-9fea-f8def2df7a76

Micha Levi 1; Alexander Berg 1; Andrea A. Berry 2; Matthew B. Laurens 3; Jennifer Winkler 4; Shayne Watson 1; B. Kim Lee Sim 5; Kayla Ann Andrews 6; Charles Wells 1; Grace Fitzgerald 7; APARNA ANDERSON 8; Kirsten E. Lyke 9; R. Scott Miller 10

Oct 24, 2025